Motivational Interviewing at Intake vs Intake as Usual on Client Engagement in Addiction Treatment
Adapting Intake Procedures to Improve Treatment Delivery in Addiction Treatment
2 other identifiers
interventional
150
1 country
1
Brief Summary
This K23 study is an effectiveness-implementation hybrid type I design to determine the effectiveness of Motivational Interviewing at Intake (MII), relative to intake-as-usual on client engagement and mechanisms of engagement among adults seeking outpatient addiction treatment. We also will obtain personnel feedback on the feasibility of implementing MII into standard practice by having personnel from the addiction treatment study sites complete implementation climate measures before Motivational Interviewing (MI) training and post-clinical trial, as well as an individual interview on implementation feasibility post-trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 16, 2022
CompletedFirst Submitted
Initial submission to the registry
July 26, 2022
CompletedFirst Posted
Study publicly available on registry
August 5, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
March 9, 2026
March 1, 2026
4.5 years
July 26, 2022
March 5, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Number of participants who attended the first outpatient treatment program session based on electronic medical record review
Treatment entry is determined by review of electronic medical record of whether clients attended their first scheduled treatment session
up to 36 weeks
Number of treatment sessions attended during the three-month outpatient treatment program based on electronic medical record review
Number of treatment sessions that clients attend is determined by review of electronic medical record and calculating number of treatment sessions attended.
up to 36 weeks
Number of participants who completed the three-month outpatient treatment program based on electronic medical record review
Completion of the three-month outpatient treatment program is determined by review of electronic medical record
up to 36 weeks
Secondary Outcomes (2)
Change from baseline in client readiness to enter treatment on the University of Rhode Island Change Assessment Scale (URICA) at 1 hour post-intake
baseline and 1 hour post-intake
Score on therapeutic alliance on the Working Alliance Inventory (WAI) at 1-hour post-intake
1 hour post-intake
Other Outcomes (3)
Change from baseline in organizational readiness to change on the Texas Christian University-Organizational Readiness to Change (TCU-ORC) at 1 year
baseline and 1 year
Change from baseline in organizational readiness to change on the Readiness for Organizational Change (ROC) at 1 year
baseline and 1 year
Change from baseline in organizational capability to change on the Change Process Capability Questionnaire (CPCQ) at Year 1
baseline and 1 year
Study Arms (2)
Motivational Interviewing at Intake (MII)
EXPERIMENTALClients allocated to the MII condition will receive a 90-minute pure Motivational Interviewing (MI) session.
Intake as Usual (IAU)
ACTIVE COMPARATORClients allocated to the IAU condition will receive the 90-minute standard assessment that is delivered to all clients entering intensive outpatient program (IOP)/outpatient program (OP).
Interventions
The MII will involve a goal-oriented and collaborative conversation about why the client wants treatment now, and how treatment might fit with his/her most important values. The provider will use open questions, reflective listening and autonomy support in a flexible, non-authoritative manner. Rather than asking specific questions in different life domains, the provider will explore with the client their desires, abilities, reasons, and needs for treatment, how treatment fits with their values, and what successful treatment looks like to them. The client's language about change will be strategically reinforced to increase its frequency and strength across the session.
In line with the American Society of Addiction Medicine (ASAM) guidelines, the IAU condition involves a semi-structured interview of the client's psychosocial history and clients answer a series of questions in the following domains: support system, living situation, educational, occupational, family, and medical history.
Eligibility Criteria
You may qualify if:
- English-speaking adults seeking treatment for alcohol or other drug use at one of two outpatient addiction treatment programs
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures
- Physically withdrawn from alcohol or other drugs
- English-speaking adults currently employed at one of the two outpatient addiction treatment programs
- Provision of electronic informed consent
You may not qualify if:
- Experiencing severe withdrawal symptoms
- Actively psychotic, manic, and/or suicidal
- current position: facility owner or clinical director
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of New Mexicolead
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (1)
UNM Psychology Clinic
Albuquerque, New Mexico, 87131, United States
Related Publications (1)
Hurlocker MC, Moyers TB, Hatch M, Curran G, McCrady B, Venner KL, Witkiewitz K. Effectiveness and feasibility of a motivational interviewing intake (MII) intervention for increasing client engagement in outpatient addiction treatment: an effectiveness-implementation hybrid design protocol. Addict Sci Clin Pract. 2023 Oct 21;18(1):63. doi: 10.1186/s13722-023-00412-y.
PMID: 37865777DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Margo Hurlocker, PhD
University of New Mexico
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 26, 2022
First Posted
August 5, 2022
Study Start
March 16, 2022
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
March 9, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Data will become available starting in January 2025
- Access Criteria
- Researchers who provide a methodologically sound proposal will have access to the data. A data use agreement will be required, signed by the requesting investigator and their Authorized Organization Representation (AOR)/Signing Official (SO)
Individual participant data that underlie results reported in a peer-reviewed publication, after deidentification (text, tables, figures, and appendices). Session audio recordings will not be shared.